Sex difference in tolerability of adjuvant oxaliplatin-based chemotherapy for colorectal cancer and changes in diagnostic components of sarcopenia: A prospective study

被引：0
|
作者：
Nozawa, Hiroaki
Abe, Shinya
Abe, Kentaro
Yokota, Yumi
Yakabe, Mitsutaka
Akishita, Masahiro
Ishihara, Soichiro
机构：
[1] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
[2] Univ Tokyo, Dept Geriatr Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
日本学术振兴会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15625
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Case of Liver Fibrosis with Splenomegaly after Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer
    Kang, Gu Hyum
    Moon, Hee Seok
    Lee, Eaum Seok
    Kim, Seok Hyun
    Sung, Jae Kyu
    Lee, Byung Seok
    Jeong, Hyun Yong
    Lee, Heon Young
    Kang, Dae Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (12) : 1835 - 1838
  • [42] Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Wang, X. S.
    Cleeland, C. S.
    Johnson, V. E.
    Reuben, J. M.
    Fogelman, D. R.
    Malekifar, M.
    Liao, K. E.
    Liu, P.
    Cohen, E. N.
    Gilmore, K. R.
    Eng, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
    Sfakianaki, Maria
    Papadaki, Chara
    Tzardi, Maria
    Trypaki, Maria
    Manolakou, Stavroula
    Messaritakis, Ippokratis
    Saridaki, Zenia
    Athanasakis, Elias
    Mavroudis, Dimitrios
    Tsiaoussis, John
    Gouvas, Nikolaos
    Souglakos, John
    CANCERS, 2020, 12 (08) : 1 - 14
  • [44] Impact of Oxaliplatin-based chemotherapy on the haemoglobin levels: A retrospective analysis in patients with colorectal cancer
    Queralt, Bernardo
    Juez, Ignacio
    Hernandez, Xavier
    Vinas, Gemma
    Rubio, Jordi
    Soler, Francesc
    Monleon, Antonio
    Colomer, Ramon
    ANNALS OF ONCOLOGY, 2004, 15 : 86 - 86
  • [45] PKM2 expression as biomarker for resistance to oxaliplatin-based chemotherapy in colorectal cancer
    Sfakianaki, M.
    Papadaki, C.
    Tzardi, M.
    Trypaki, M.
    Manolakou, S.
    Messaritakis, I.
    Saridaki, Z.
    Mavroudis, D.
    Georgoulias, V.
    Souglakos, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Real-world impact on overall survival of oxaliplatin-based adjuvant chemotherapy in older patients with colorectal cancer in Mexico.
    Herrera, Marytere
    Garcia, Elizabeth
    Diaz, Consuelo
    Ruiz-Garcia, Erika
    Adame, Sayako Miyagui
    Hernandez, Stefan Zilli
    Lopez, Mextli
    Carbajal, Berenice
    Ruiz, German Calderillo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 61 - 61
  • [47] ERCC1 and ERCC2 polymorphisms predict the clinical outcomes of oxaliplatin-based adjuvant chemotherapy in colorectal cancer
    Shi, Lei
    Wang, Ran
    Wu, Wen-ming
    Huang, Yi-fei
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (32): : 2429 - 2432
  • [48] Oxaliplatin-based Chemotherapy in Patients Aged 75 Years or Older with Metastatic Colorectal Cancer
    Fukuchi, Minoru
    Ishibashi, Keiichiro
    Tajima, Yusuke
    Okada, Norimichi
    Yokoyama, Masaru
    Chika, Noriyasu
    Hatano, Satoshi
    Matsuzawa, Takeaki
    Kumamoto, Kensuke
    Kumagai, Youichi
    Baba, Hiroyuki
    Mochiki, Erito
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2013, 33 (10) : 4627 - 4630
  • [49] ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
    Baek, Moo-Jun
    ANNALS OF COLOPROCTOLOGY, 2015, 31 (03) : 81 - 81
  • [50] Pharmacogenetic prediction of clinical outcome in gastric cancer patients receiving oxaliplatin-based adjuvant chemotherapy
    Liu, Y.
    Ling, Y.
    Liu, B.
    Zhang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345